BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33760210)

  • 1. BCAT1 overexpression regulates proliferation and c‑Myc/GLUT1 signaling in head and neck squamous cell carcinoma.
    Wang H; Wang F; Ouyang W; Jiang X; Wang Y
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of GLUT1 on the survival of head and neck squamous cell carcinoma.
    Li S; Yang X; Wang P; Ran X
    Cell Physiol Biochem; 2013; 32(3):624-34. PubMed ID: 24022001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation.
    Li Z; Meng D; Liu Y; Bi F; Tian K; Xu J; Sun J; Gu C; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23537. PubMed ID: 37700640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
    Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
    Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
    [No Abstract]   [Full Text] [Related]  

  • 5. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
    Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
    Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
    Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
    Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Zhou W; Feng X; Ren C; Jiang X; Liu W; Huang W; Liu Z; Li Z; Zeng L; Wang L; Zhu B; Shi J; Liu J; Zhang C; Liu Y; Yao K
    Mol Cancer; 2013 Jun; 12():53. PubMed ID: 23758864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma.
    Ji X; Guo X; Wang Y; Li X; Li H
    Onco Targets Ther; 2020; 13():4123-4134. PubMed ID: 32494165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
    Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
    Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
    Wang S; Chen X; Qiao T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
    Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
    Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 14. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flotillin-2 promotes cell proliferation via activating the c-Myc/BCAT1 axis by suppressing miR-33b-5p in nasopharyngeal carcinoma.
    Liu R; Liu J; Wu P; Yi H; Zhang B; Huang W
    Aging (Albany NY); 2021 Mar; 13(6):8078-8094. PubMed ID: 33744853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
    Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
    Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
    Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
    Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin.
    Wang YD; Li SJ; Liao JX
    Technol Cancer Res Treat; 2013 Dec; 12(6):525-35. PubMed ID: 23617290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.
    Thewes V; Simon R; Hlevnjak M; Schlotter M; Schroeter P; Schmidt K; Wu Y; Anzeneder T; Wang W; Windisch P; Kirchgäßner M; Melling N; Kneisel N; Büttner R; Deuschle U; Sinn HP; Schneeweiss A; Heck S; Kaulfuss S; Hess-Stumpp H; Okun JG; Sauter G; Lykkesfeldt AE; Zapatka M; Radlwimmer B; Lichter P; Tönjes M
    Oncogene; 2017 Jul; 36(29):4124-4134. PubMed ID: 28319069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
    Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.